Xilio Therapeutics (XLO) Q3 2025 Earnings

Aug 14Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.25
-0.19
-0.13
-0.08

Details

Expected EPS
-0.0788
Actual EPS
-0.16
Surprise EPS
-0.08
Surprise Percent
-103.05%

Description

⁨Xilio Therapeutics⁩ (⁦XLO⁩) has reported earnings of ⁦-0.16⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts